Energy Restriction Negates NMDA Receptor Antagonist Efficacy in Ischemic Stroke
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Preclinical evaluation of drugs for neurological disorders is usually performed on overfed rodents, without consideration of how metabolic state might affect drug efficacy. Using a widely employed mouse model of focal ischemic stroke, we found that that the NMDA receptor antagonist dizocilpine (MK-801) reduces brain damage and improves functional outcome in mice on the usual ad libitum diet, but exhibits little or no therapeutic efficacy in mice maintained on an energy-restricted diet. Thus, NMDA receptor activation plays a central role in the mechanism by which a high dietary energy intake exacerbates ischemic brain injury. These findings suggest that inclusion of subjects with a wide range of energy intakes in clinical trials for stroke may mask a drug benefit in the overfed/obese subpopulation of subjects.
- Albers, G. W., Goldstein, L. B., Hall, D., Lesko, L. M., & Aptiganel Acute Stroke Investigators. (2001). Aptiganel hydrochloride in acute ischemic stroke: A randomized controlled trial. JAMA, 286, 2673–2682. CrossRef
- Arumugam, T. V., Phillips, T. M., Cheng, A., Morrell, C. H., Mattson, M. P., & Wan, R. (2010). Age and energy intake interact to modify cell stress pathways and stroke outcome. Annals of Neurology, 67, 41–52. CrossRef
- Boxer, P. A., Cordon, J. J., Mann, M. E., Rodolosi, L. C., Vartanian, M. G., Rock, D. M., et al. (1990). Comparison of phenytoin with noncompetitive N-methyl-d-aspartate antagonists in a model of focal brain ischemia in rat. Stroke, 21, S47–S51. CrossRef
- Cheng, B., & Mattson, M. P. (1994). NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Research, 640, 56–67. CrossRef
- Hyun, D. H., Emerson, S. S., Jo, D. G., Mattson, M. P., & de Cabo, R. (2006). Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proceedings of the National Academy of Sciences USA, 103, 19908–199912. CrossRef
- Kochhar, A., Zivin, J. A., Lyden, P. D., & Mazzarella, V. (1988). Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Archives of Neurology, 45, 148–153.
- Ma, J., Endres, M., & Moskowitz, M. A. (1998). Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. British Journal of Pharmacology, 124, 756–762. CrossRef
- Martin, B., Ji, S., Maudsley, S., & Mattson, M. P. (2010). “Control” laboratory rodents are metabolically morbid: Why it matters. Proceedings of the National Academy of Sciences USA, 107, 6127–6133. CrossRef
- Martin, B., Mattson, M. P., & Maudsley, S. (2006). Caloric restriction and intermittent fasting: Two potential diets for successful brain aging. Ageing Research Reviews, 5, 332–353. CrossRef
- Mattson, M. P., Lovell, M. A., Furukawa, K., & Markesbery, W. R. (1995). Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2 + concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. Journal of Neurochemistry, 65, 1740–1751. CrossRef
- Minematsu, K., Fisher, M., Li, L., Davis, M. A., Knapp, A. G., Cotter, R. E., et al. (1993). Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology, 43, 397–403.
- Robertson, C., Goodman, J. C., Grossman, R. G., Claypool, M., & White, A. (1992). Dietary nonprotein calories and cerebral infarction size in rats. Stroke, 23, 564–568. CrossRef
- Stranahan, A. M., Lee, K., Martin, B., Maudsley, S., Golden, E., Cutler, R. G., et al. (2009). Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus, 19, 951–961. CrossRef
- Tureyen, K., Bowen, K., Liang, J., Dempsey, R. J., & Vemuganti, R. (2011). Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. Journal of Neurochemistry, 116, 499–507. CrossRef
- Uranga, R. M., Bruce-Keller, A. J., Morrison, C. D., Fernandez-Kim, S. O., Ebenezer, P. J., Zhang, L., et al. (2010). Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. Journal of Neurochemistry, 114, 344–361.
- Yoon, J. S., Lee, J. H., Son, T. G., Mughal, M. R., Greig, N. H., & Mattson, M. P. (2011). Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome. Neurobiology of Disease, 41, 624–629. CrossRef
- Energy Restriction Negates NMDA Receptor Antagonist Efficacy in Ischemic Stroke
Volume 13, Issue 3 , pp 175-178
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- Cerebral ischemia
- Industry Sectors